Sorin collects EU approval for its Intensia family of cardiac devices

Intensia ICD and CRT-D implant--Courtesy of Sorin

Notching another CE mark in its cardiac cache, Italian devicemaker Sorin nabbed European approval for its Intensia family of implantable cardiac defibrillator and cardiac resynchronization therapy (CRT) devices. The batch of devices includes both a single-chamber and a dual-chamber implant, as well as one with Sorin's self-adjusting SonR algorithm, which has shown in the clinic to improve CRT response by 23%. And all of the Intensia devices use the DF-4 high-voltage connector, which requires only one connection as opposed to two or three and has become an industry standard. Sorin is expecting big growth next year with its focus on new products, and just last month the company picked up another CE mark for its stentless aortic valve replacement Freedom Solo Smart. Release

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

A COVID-19 antibody diagnostic developed through a joint venture between Mount Sinai Health System and RenalytixAI has been authorized by the FDA.

Researchers at Northwestern University have trained an AI algorithm to automatically detect the signs of COVID-19 on a basic X-ray of the lungs.

Hand-held ultrasound developer Butterfly Network is going public through a $1.5 billion acquisition deal backed by Glenview Capital.